Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasiaPeter J Baldwin, Sjoerd H van der Burg, Christopher M Boswell, et al.
Plos Pathogens|May 30, 2013
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune responseRezaul Karim, Bart Tummers, Craig Meyers, et al.
Nature Chemical Biology|December 24, 2005
C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40LSylvie Fournel, Sébastien Wieckowski, Weimin Sun, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)Riccardo Pecori, Beatrice Casati, Rona Merdler-Rabinowicz, et al.
Journal of Medicinal Chemistry|September 27, 2024
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against CancerJeffrey Mowat, Rafael Carretero, Gabriele Leder, et al.
Cancer Discovery|October 27, 2020
Timed Ang2-Targeted Therapy Identifies the Angiopoietin-Tie Pathway as Key Regulator of Fatal Lymphogenous MetastasisNicolas Gengenbacher, Mahak Singhal, Carolin Mogler, et al.
International Journal of Cancer|September 10, 2005
Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus diseaseMarij J P Welters, Pauline van der Logt, Susan J F van den Eeden, et al.
Frontiers in Immunology|January 11, 2020
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome DisplayStina L Wickström, Tanja Lövgren, Michael Volkmar, et al.
Blood|September 30, 2004
SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicityMichael Bots, Ingrid G M Kolfschoten, Sandra A Bres, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradicationGeertje J D van Mierlo, Zita F H M Boonman, Hélène M H Dumortier, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasiaPeter J Baldwin, Sjoerd H van der Burg, Christopher M Boswell, et al.
Plos Pathogens|May 30, 2013
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune responseRezaul Karim, Bart Tummers, Craig Meyers, et al.
Nature Chemical Biology|December 24, 2005
C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40LSylvie Fournel, Sébastien Wieckowski, Weimin Sun, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)Riccardo Pecori, Beatrice Casati, Rona Merdler-Rabinowicz, et al.
Journal of Medicinal Chemistry|September 27, 2024
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against CancerJeffrey Mowat, Rafael Carretero, Gabriele Leder, et al.
Cancer Discovery|October 27, 2020
Timed Ang2-Targeted Therapy Identifies the Angiopoietin-Tie Pathway as Key Regulator of Fatal Lymphogenous MetastasisNicolas Gengenbacher, Mahak Singhal, Carolin Mogler, et al.
International Journal of Cancer|September 10, 2005
Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus diseaseMarij J P Welters, Pauline van der Logt, Susan J F van den Eeden, et al.
Frontiers in Immunology|January 11, 2020
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome DisplayStina L Wickström, Tanja Lövgren, Michael Volkmar, et al.
Blood|September 30, 2004
SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicityMichael Bots, Ingrid G M Kolfschoten, Sandra A Bres, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradicationGeertje J D van Mierlo, Zita F H M Boonman, Hélène M H Dumortier, et al.
Pageof 12